DCG International Investments Ltd filed a Form 144 notice on November 3, 2026, disclosing a proposed sale of 20,200 common shares of Grayscale Bitcoin Cash Trust (BCH) on the OTCQX market, with an aggregate market value of $41,626.14.
DCG International Investments Ltd filed a Form 144 notice on November 3, 2026, disclosing a proposed sale of 440 common shares of Grayscale Livepeer Trust (LPT) on the OTCQB market, with an aggregate market value of $765.60.
Digital Currency Group, Inc. filed a Form 144 notice of proposed sale of securities with the SEC on November 3, 2026, disclosing plans to sell 6,992 shares of Grayscale Horizen Trust (ZEN) common stock through broker Canaccord Genuity Inc.
Margaret C. Egan, an officer of Hyatt Hotels Corporation, filed a Form 144 notice of proposed sale of 1,100 shares of common stock on November 3, 2026, disclosing her intent to sell through Morgan Stanley Smith Barney LLC.
A Form 144 notice of proposed sale was filed on November 3, 2026, by the Mark Hoplamazian Revocable Trust, disclosing a planned sale of 22,876 shares of Hyatt Hotels Corporation common stock on the NYSE.
Anthony Christopher Lee, identified in the filing as "Chris Anthony," an officer and director of Aptera Motors Corp, filed a Form 144 notice of proposed sale on November 3, 2026, covering 6,145 Class B shares acquired through restricted stock vesting.
RYPS, LLC filed a Form 144 notice on November 3, 2026, disclosing a proposed sale of 1,924,478 shares of Ryerson Holding Corp common stock through J.P. Morgan Securities LLC on the New York Stock Exchange.
Richard Reiss, an officer of Exponent, Inc., filed a Form 144 notice of proposed sale of securities on November 3, 2026, covering 1,280 shares of Exponent common stock with an aggregate market value of $110,643.20.
Bowhead Specialty Holdings Inc. filed definitive additional proxy materials on November 3, 2026, supplementing its October 14, 2026 proxy statement ahead of a special stockholder meeting scheduled for November 13, 2026, to vote on the company's proposed merger with American Family Mutual Insurance Company, …
Pfizer Inc. filed an 8-K on November 3, 2026, disclosing that its Board of Directors unanimously elected Cecile Guegan as Chief Financial Officer and Executive Vice President, effective November 1, 2026.